Medical treatments based on anamorelin
Methods of treating cancer related conditions using anamorelin are described.
1. A method of treating cachexia in a human patient having a body mass index less than 20 kg/m 2 , comprising administering to the patient a therapeutically effective amount of anamorelin once daily for a therapeutically effective period of time.
2. A method of treating cachexia in a human patient having a body mass index less than 20 kg//m 2 , comprising administering to the patient a therapeutically effective amount of anamorelin once daily for a therapeutically effective period of time and increasing total body mass of the patient.
3. A method of treating cachexia in a human patient having a body mass index less than 20 kg/m 2 , comprising administering to the patient a therapeutically effective amount of anamorelin on a daily basis for a therapeutically effective period of time and improving quality of life in the patient as measured by FAACT in the anorexia/cachexia domain.
4. A method of treating cachexia in a human patient having a body mass index less than 20 kg/m 2 , comprising administering to the patient a therapeutically effective amount of anamorelin once daily for a therapeutically effective period of time, increasing total body mass of the patient, and improving quality of life in the patient as measured by a subset of symptoms questions on FAACT in the anorexia/cachexia domain.
5. The method of claim 1 , wherein the patient has a body weight loss greater than or equal to 2% in the previous 6 months.
6. The method of claim 1 , further comprising increasing total body mass of the patient.
7. The method of claim 1 , further comprising improving quality of life in the patient as measured by FAACT in the anorexia/cachexia domain.
8. The method of claim 1 , further comprising increasing total body mass of the patient and improving quality of life in the patient as measured by FAACT in the anorexia/cachexia domain.
9. The method of claim 2 , wherein the patient has a body weight loss greater than or equal to 2% in the previous 6 months.
10. The method of claim 2 , further comprising improving quality of life in the patient as measured by FAACT in the anorexia/cachexia domain.
11. The method of claim 3 , wherein the patient has a body weight loss greater than or equal to 2% in the previous 6 months.
12. The method of claim 4 , wherein the patient has a body weight loss greater than or equal to 2% in the previous 6 months.